Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from britain
β Scribed by Christine Challen; John Lunec; William Warren; Jane Collier; Dr. Margaret F. Bassendine
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 530 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
Human hepatocellular carcinomas from patients in Britain, an area of low prevalence of hepatocellular carcinoma and low dietary exposure to aflatoxin B,, were analyzed for mutations in the p53 tumorsuppressor gene. Abnormalities in the pS3 gene were detected in 2 of 19 hepatocellular carcinomas by polymerase chain reaction-single-stranded conformation polymorphism. Direct sequencing of the evolutionarily conserved regions of pS3 (exons 6.6.7 and 81, where mutations have been commonly found in a variety of tumors, confirmed that only two hepatocellular carcinomas had mutations in pS3, one a 6-bp deletion of codons 158 and 159 (exon 5 ) and the other a G to A transition at codon 286 (exon 8). No mutations were found in any hepatocellular carcinoma in exons 6 and 7; in particular all tumors had wild-type sequence at codon 249, which has been reported to be a mutational hot spot in the pS3 gene in hepatocellular carcinomas from high incidence areas such as China and southern Africa. Abnormalities in p53 expression were examined by immunohistochemistry and found in 1 of the 19 hepatocellular carcinomas. These findings show that pS3 mutations are infrequently involved in the malignant transformation of hepatocytes in an area of low hepatocellular carcinoma prevalence. They support the suggestion of a possible link between dietary exposure to &atoxin and selective G to T mutations at codon 249 of the pS3 gene. Our observations also indicate that hepatitis B virus infection alone, present in six of the hepatocellular carcinomas examined, does not account for the specificity for codon 249 mutations reported from endemic areas.
π SIMILAR VOLUMES
BACKGROUND. Specific mutations of the p53 tumor suppressor gene in hepatocellular carcinoma (HCC) have been reported from several parts of the world, but to the authors' knowledge to date the status of this gene has not been studied in HCC patients in India, where HCC is one of the major cancers and
Abnormalities of the tumor-suppressor p53 gene have been discovered in human hepatocellular carcinoma (HCC). It is unclear, however, whether HCC related to chronic viral hepatitis is associated with p53 gene alterations. In this study, we have examined p53 abnormalities in HCC associated with hepati
In this study, we analyzed 10 human squamous cell carcinomas (SCCs) for alterations in the p53 tumor suppressor gene in exons 4 through 9 by single-strand conformation polymorphism (SSCP) analysis. We found that 2 of 10 SCCs displayed unusual SSCP alleles at exon 7 of the p53 gene. Subsequent clonin
## Abstract Immunohistochemical, immunoblotting, and DNAβsequencing analyses were performed on hepatocellular carcinomas induced in rats chronically fed BR931, a peroxisome proliferator, to determine whether the tumors carried mutations or other alterations of the __p53__ gene. None were detected.
The prognostic significance and nature of p53 dysfunction in ovarian carcinoma is unclear. The relation between p53 overexpression, p53 mutations, and their effects on overall survival in primary ovarian carcinoma is explored. ## METHODS. Tumor specimens from 171 consecutive epithelial ovarian ca